top
HOME PAGE

Stem Cells | Treatment > Cancer Stem Cells

top


Contents



Basic Science


Massard C, Deutsch E, Soria JC
Tumour stem cell-targeted treatment: elimination or differentiation
Ann Oncol. 2006 Nov;17(11):1620-4. Epub 2006 May 3
 Abstract |  Reprint |
Links | BL 7:6

Maximilian Diehn and Michael F. Clarke
Cancer Stem Cells and Radiotherapy: New Insights Into Tumor Radioresistance
JNCI Journal of the National Cancer Institute, 98(24):1755-1757;
20 December 2006; doi:10.1093/jnci/djj505
Abstract | Full Text | Reprint | Links

Jeremy N. Rich
Cancer Stem Cells in Radiation Resistance
Cancer Research 67, 8980-8984, October 1, 2007. doi: 10.1158/0008-5472.CAN-07-0895
Abstract | Reprint | Links | BL 7:2

Isidro Sanchez-Garcia and Perez-Caro Maria
Cancer Stem Cells (CSC) ablation as a treatment strategy for cancer
AACR Meeting Abstracts, Apr 2006; 2006: 73
Abstract | Links | BL 7:1

Wu YY, Huang Q, Dong J, Lan Q
Correlation of stem cell niche to genesis and development of tumor stem cells
Ai Zheng. 2008 Jan;27(1):109-12
Abstract |  Links | BL 7:2


Brain Tumors


Boockvar JA, Howard BM
Brain tumor stem cells: will understanding a new paradigm lead to improved therapies?
Expert Rev Neurother. 2008 Apr;8(4):511-4
 Abstract |  Full Text |  Reprint |
Links | BL 7:9

Nicoletti F, Arcella A, Iacovelli L, Battaglia G, Giangaspero F, Melchiorri D. 
Metabotropic glutamate receptors: new targets for the control of tumor growth?
Trends Pharmacol Sci. 2007 Apr 1
1; [Epub ahead of print]
Abstract
| Links

Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M, Dirks PB.
Chemical genetics reveals a complex functional ground state of neural stem cells
Nat Chem Biol. 2007 Apr 8; [Epub ahead of print]
PMID: 17417631 [PubMed - as supplied by publisher]
Full Text | Reprint | Links

Skog J, Edlund K, Bergenheim AT, Wadell G
Adenoviruses 16 and CV23 efficiently transduce human low-passage brain tumor and cancer stem cells
Mol Ther. 2007 Dec;15(12):2140-5. Epub 2007 Sep 18
 Abstract |
Links | BL 7:5

Tu LC, Foltz G, Lin E, Hood L, Tian Q
Targeting stem cells-clinical implications for cancer therapy
Curr Stem Cell Res Ther. 2009 May;4(2):147-53
  Abstract |   Links |   Issue

Patrizia Tunici, Ph.D., Dwain Irvin, Ph.D., M.P.H., Gentao Liu, Ph.D., Xiangpeng Yuan, Ph.D., Zeng Zhaohui, Ph.D., Hiushan Ng, M.S., and John S. Yu, M.D.
Brain tumor stem cells: new targets for clinical treatments?
Neurosurg Focus 20 (4):E27, April 2006
Abstract | Full Text | Reprint | Links


Glioblastoma


Annabi B, Lachambre MP, Plouffe K, Sartelet H, Béliveau R
Modulation of invasive properties of CD133(+) glioblastoma stem cells: A role for MT1-MMP in bioactive lysophospholipid signaling
Mol Carcinog. 2009 Mar 26;. [Epub ahead of print]
  Abstract |   Links |   Issue

Beier D, Röhrl S, Pillai DR, Schwarz S, Kunz-Schughart LA, Leukel P, Proescholdt M, Brawanski A, Bogdahn U, Trampe-Kieslich A, Giebel B, Wischhusen J, Reifenberger G, Hau P, Beier CP
Temozolomide preferentially depletes cancer stem cells in glioblastoma
Cancer Res. 2008 Jul 15;68(14):5706-15
 Abstract |  Reprint |
Links | BL 7:15

Bertrand J, Begaud-Grimaud G, Bessette B, Verdier M, Battu S, Jauberteau MO
Cancer stem cells from human glioma cell line are resistant to Fas-induced apoptosis
Int J Oncol. 2009 Mar;34(3):717-27
  Abstract |   Links |   Issue

Castriconi R, Daga A, Dondero A, Zona G, Poliani PL, Melotti A, Griffero F, Marubbi D, Spaziante R, Bellora F, Moretta L, Moretta A, Corte G, Bottino C
NK cells recognize and kill human glioblastoma cells with stem cell-like properties
J Immunol. 2009 Mar 15;182(6):3530-9
  Abstract |   Links |   Issue


Chang CJ, Hsu CC, Yua MC, Chen KY, Tzao C, Wu WF, Chou HY, Lu KH, Chiou SH, Ma HI.
Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression
Biochem Biophys Res Commun. 2009 Jan 21. [Epub ahead of print]
  Abstract |   Links |   Issue

Eli E. Bar, Aneeka Chaudhry, Alex Lin, Xing Fan, Karisa Schreck, William Matsui, Sara Piccirillo, Angelo L. Vescovi, Francesco DiMeco, Alessandro Olivi, Charles G. Eberhart
Cyclopamine-Mediated Hedgehog Pathway Inhibition Depletes Stem-Like Cancer Cells in Glioblastoma
Stem Cells Oct 2007; 25: 2524 - 2533 ; doi:10.1634/stemcells.2007-0166
Abstract | Links | BL 7:1

Chearwae W, Bright JJ
PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells
Br J Cancer. 2008 Nov 18. [Epub ahead of print]
  Abstract |   Links |   Issue

Gal H, Pandi G, Kanner AA, Ram Z, Lithwick-Yanai G, Amariglio N, Rechavi G, Givol D.
MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells
Biochem Biophys Res Commun. 2008 Aug 31; [Epub ahead of print]
 Abstract |
Links |  BL 7:18

Gallia GL, Tyler BM, Hann CL, Siu IM, Giranda VL, Vescovi AL, Brem H, Riggins GJ
Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells
Mol Cancer Ther. 2009 Feb;8(2):386-93. Epub 2009 Feb 10
  Abstract |   Links |   Issue

Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC, Malatesta P, Ravetti GL, Zona GL, Daga A, Corte G
SOX2 Silencing in Glioblastoma Tumor Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity
Stem Cells. 2008 Oct 23; [Epub ahead of print]
  Abstract |
Links |   Issue

Jurvansuu J, Zhao Y, Leung DS, Boulaire J, Yu YH, Ahmed S, Wang S
Transmembrane protein 18 enhances the tropism of neural stem cells for glioma cells
Cancer Res. 2008 Jun 15;68(12):4614-22
 Abstract | Full Text | Reprint | Links | BL 7:13

Kang MK, Kang SK
Pharmacologic blockade of chloride channel synergistically enhances apoptosis of chemotherapeutic drug-resistant cancer stem cells
Biochem Biophys Res Commun. 2008 Jun 30; [Epub ahead of print]
 Abstract |
Links | BL 7:14

Kast RE, Belda-Iniesta C.
Suppressing Glioblastoma Stem Cell Function by Aldehyde Dehydrogenase Inhibition with Chloramphenicol or Disulfiram as a New Treatment Adjunct: An Hypothesis
Curr Stem Cell Res Ther. 2009 Dec 1;. [Epub ahead of print]
  Abstract |   Links |   Issue

Rappa G, Mercapide J, Anzanello F, Prasmickaite L, Xi Y, Ju J, Fodstad O, Lorico A
Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets
Exp Cell Res. 2008 Mar 20; [Epub ahead of print]
 Abstract |
Links | BL 7:9

Akihiro Otsuki, Suzanne Camilli, Ankita Patel, Shigeru Tanaka, E. Antonio Chiocca, and Yoshinaga Saeki
Characterizing an oncolytic virotherapy targeted towards brain tumor stem cells
AACR Meeting Abstracts, Apr 2006; 2006: 703
Abstract | Links | BL 7:1

Sara GM Piccirillo, Angelo L Vescovi PhD
Brain tumour stem cells: possibilities of new therapeutic strategies
Expert Opinion on Biological Therapy, August 2007, Vol. 7, No. 8, Pages 1129-1135
Abstract | Links

S. G. M. Piccirillo, B. A. Reynolds, N. Zanetti, G. Lamorte, E. Binda, G. Broggi, H. Brem, A. Olivi, F. Dimeco and A. L. Vescovi
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
Nature 444, 761-765 (7 December 2006). doi:10.1038/nature05349
Abstract |
Reprint | Links

Tunici P, Pellegatta S, Finocchiaro G.
The potential of stem cells for the treatment of brain tumors and globoid cell leukodystrophy
Cytotechnology. 2003 Mar;41(2-3):93-101
  Abstract |   Links |   Issue

Wakimoto H, Kesari S, Farrell CJ, Curry WT Jr, Zaupa C, Aghi M, Kuroda T, Stemmer-Rachamimov A, Shah K, Liu TC, Jeyaretna DS, Debasitis J, Pruszak J, Martuza RL, Rabkin SD
Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors
Cancer Res. 2009 Apr 15;69(8):3472-81. Epub 2009 Apr 7
  Abstract |   Links |   Issue

Xu Q, Liu G, Yuan X, Xu M, Wang H, Ji J, Konda B, Black KL, Yu JS.
Antigen-Specific T Cell Response from Dendritic Cell Vaccination Using Cancer Stem-like Cell-Associated Antigens
Stem Cells. 2009 Apr 23;. [Epub ahead of print]
  Abstract |   Links |   Issue

Yuki K, Natsume A, Yokoyama H, Kondo Y, Ohno M, Kato T, Chansakul P, Ito M, Kim SU, Wakabayashi T.
Induction of oligodendrogenesis in glioblastoma-initiating cells by IFN-mediated activation of STAT3 signaling
Cancer Lett. 2009 May 18;. [Epub ahead of print]
  Abstract |   Links |   Issue

Ziegler DS, Wright RD, Kesari S, Lemieux ME, Tran MA, Jain M, Zawel L, Kung AL.
Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins
J Clin Invest. 2008 Aug 1; [Epub ahead of print]
 Abstract |  Full Text |  Reprint |
Links | BL 7:16


Gliomas


Bexell D, Gunnarsson S, Siesjö P, Bengzon J, Darabi A
CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas
Int J Cancer. 2009 Feb 3. [Epub ahead of print]
  Abstract |   Links |   Issue

Eyler CE, Foo WC, Lafiura KM, McLendon RE, Hjelmeland AB, Rich JN.
Brain Cancer Stem Cells Display Preferential Sensitivity to Akt Inhibition
Stem Cells. 2008 Sep 18; [Epub ahead of print]
  Abstract |
  Links |   BL 7:19

Friedman GK, Langford CP, Coleman JM, Cassady KA, Parker JN, Markert JM, Yancey Gillespie G.
Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111
J Neurooncol. 2009 Jun 12;. [Epub ahead of print]
  Abstract |   Links |   Issue

Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca EA, Lawler S
Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal
Cancer Res. 2008 Nov 15;68(22):9125-30
  Abstract |   Links |   Issue

Li Z, Wang H, Eyler CE, Rich JN
Turning cancer stem cells inside-out: an exploration of glioma stem cell signaling pathways
J Biol Chem. 2009 Mar 13;. [Epub ahead of print]
  Abstract |   Reprint |   Links |   Issue

Sasportas LS, Kasmieh R, Wakimoto H, Hingtgen S, van de Water JA, Mohapatra G, Figueiredo JL, Martuza RL, Weissleder R, Shah K
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4822-7. Epub 2009 Mar 5
  Abstract |   Links |   Issue

Thon N, Damianoff K, Hegermann J, Grau S, Krebs B, Schnell O, Tonn JC, Goldbrunner R.
Presence of pluripotent CD133(+) cells correlates with malignancy of gliomas
Mol Cell Neurosci. 2008 Aug 7; [Epub ahead of print]
  Abstract |
Links |  BL 7:18


Gliomas (High-Grade)


Aguado T, Carracedo A, Julien B, Velasco G, Milman G, Mechoulam R, Alvarez L, Guzmán M, Galve-Roperh I
Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis
J Biol Chem. 2007 Mar 2;282(9):6854-62. Epub 2007 Jan 2
 Abstract |  Full Text |  Reprint |
Links | BL 7:5

Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, Hjelmeland AB, Rich JN.
Targeting cancer stem cells through L1CAM suppresses glioma growth
Cancer Res. 2008 Aug 1;68(15):6043-8
 Abstract |  Reprint |
Links | BL 7:16

Folkins C, Man S, Xu P, Shaked Y, Hicklin DJ, Kerbel RS
Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors
Cancer Res. 2007 Apr 15;67(8):3560-4
 Abstract |  Reprint |
Links | BL 7:5

A. G. Gilg, S. L. Tye, L. B. Tolliver, W. G. Wheeler, R. P. Visconti, J. D. Duncan, F. V. Kostova, L. N. Bolds, B. P. Toole, and B. L. Maria
Targeting Hyaluronan Interactions in Malignant Gliomas and Their Drug-Resistant Multipotent Progenitors
Clin. Cancer Res., March 15, 2008; 14(6): 1804 - 1813
 Abstract |
Links | BL 7:6

Kendall SE, Najbauer J, Johnston HF, Metz MZ, Li S, Bowers M, Garcia E, Kim SU, Barish ME, Aboody KS, Glackin CA
Neural Stem Cell Targeting of Glioma is Dependent on PI3K Signaling
Stem Cells. 2008 Mar 13; [Epub ahead of print]
Abstract |  Reprint | Supplemental Data |
Links | BL 7:7

Laks DR, Masterman-Smith M, Visnyei K, Angenieux B, Orozco NM, Foran I, Yong WH, Vinters HV, Liau LM, Lazareff JA, Mischel PS, Cloughesy TF, Horvath S, Kornblum HI
Neurosphere formation is an independent predictor of clinical outcome in malignant glioma
Stem Cells. 2009 Apr;27(4):980-7
  Abstract |   Links |   Issue

Serena Pellegatta, Pietro Luigi Poliani, Daniela Corno, Francesca Menghi, Francesco Ghielmetti, Blanca Suarez-Merino, Valentina Caldera, Sara Nava, Maria Ravanini, Fabio Facchetti, Maria Grazia Bruzzone, and Gaetano Finocchiaro
Neurospheres Enriched in Cancer Stem–Like Cells Are Highly Effective in Eliciting a Dendritic Cell–Mediated Immune Response against Malignant Gliomas
Cancer Res 2006 Nov 1; 66: 10247-10252
Abstract | Reprint | Links

Sauvageot CM, Weatherbee JL, Kesari S, Winters SE, Barnes J, Dellagatta J, Ramakrishna NR, Stiles CD, Kung AL, Kieran MW, Wen PY.
Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells
Neuro Oncol. 2008 Aug 5; [Epub ahead of print]
 Abstract |
Links | BL 7:16

Wu A, Wiesner S, Xiao J, Ericson K, Chen W, Hall WA, Low WC, Ohlfest JR
Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy
J Neurooncol. 2007 Jun;83(2):121-31. Epub 2006 Nov 1. Erratum in: J Neurooncol. 2007 Jun;83(2):133
 Abstract |  Reprint |
Links | BL 7:5


Medulloblastoma


Annabi B, Rojas-Sutterlin S, Laflamme C, Lachambre MP, Rolland Y, Sartelet H, Béliveau R
Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype
Mol Cancer Res. 2008 Jun;6(6):907-16
 Abstract |  Full Text |  Reprint | Links | BL 7:13

Lu KH, Chen YW, Tsai PH, Tsai ML, Lee YY, Chiang CY, Kao CL, Chiou SH, Ku HH, Lin CH, Chen YJ
Evaluation of radiotherapy effect in resveratrol-treated medulloblastoma cancer stem-like cells
Childs Nerv Syst. 2009 Feb 19. [Epub ahead of print]
  Abstract |   Links |   Issue

Xing Fan, William Matsui, Leila Khaki, Jiong Chun, Yue-Ming Li, and Charles G. Eberhart
Notch pathway blockade targets medulloblastoma-initiating cancer stem cells
AACR Meeting Abstracts, Apr 2006; 2006: 1053
Abstract | Links | BL 7:1


Metastasis


M. Mimeault, R. Hauke, P. P. Mehta, S. K. Batra
Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers
J Cell Mol Med. Volume 11, Issue 5, Page 981-1011, Sep 2007, doi: 10.1111/j.1582-4934.2007.00088.x
 Abstract |  Full Text |  Reprint |
Links | BL 7:6

Neuroblastoma


Tsuchida R, Das B, Yeger H, Koren G, Shibuya M, Thorner PS, Baruchel S, Malkin D.
Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling
Oncogene. 2008 Jun 26;27(28):3923-34. Epub 2008 Mar 10
 Abstract |
Links | BL 7:15


HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
| Children's Corner | Current Neuro-Oncology | E-mail Alerts | Journals | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP
bottom